-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Gomisin G
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/62956-48-3.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 62956-48-3 |
| Description | Gomisin G exhibited the most potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 microgram/mL and 300. |
Product Information
| Synonyms | Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxol-7,8-, |
| Molecular Weight | 536.6 |
| Molecular Formula | C30H32O9 |
| Canonical SMILES | CC1CC2=CC(=C(C(=C2C3=C(C4=C(C=C3C(C1(C)O)OC(=O)C5=CC=CC=C5)OCO4)OC)OC)OC)OC |
| InChI | 1S/C30H32O9/c1-16-12-18-13-20(33-3)24(34-4)26(35-5)22(18)23-19(14-21-25(27(23)36-6)38-15-37-21)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1 |
| InChIKey | OFDWKHIQKPKRKY-DSASHONVSA-N |
| Boiling Point | 670.9±55.0 °C at 760 mmHg |
| Flash Point | 217.2±25.0 °C |
| Purity | >98% |
| Density | 1.3±0.1 g/cm3 |
| Solubility | Soluble in DMSO |
| Appearance | Powder |
| Application | anti-HIV |
| Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Storage | Store at -20 °C |
| Complexity | 833 |
| Exact Mass | 536.20463259 |
| Index Of Refraction | 1.623 |
| PSA | 101.91000 |
| Target | HIV |
| Vapor Pressure | 0.0±2.2 mmHg at 25°C |
| XLogP3-AA | 5 |
